Latest filing published 27 Jun 2025 for Regulus Therapeutics Inc.. Read the official filing
All filings by Crispina Calsada on record concern Regulus Therapeutics Inc. Over a trading history stretching from 12 January 2024 to 25 June 2025, the count stands at 5 filings.
Sales make up the whole of the open-market record (2 sales, €54k). Other entries cover 2 share grants. In 2025 alone, the filings show no purchases and 1 sale.
The latest filing, published on 27 June 2025, reports a transaction in Regulus Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations